You are here

Article info

Article menu
XML
Immunotherapy biomarkers
Original research
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer

Authors

  • Shujing Wang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Hua Zhu Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Yingjie Li Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Jin Ding Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Feng Wang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Lixin Ding Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Xinyu Wang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Jun Zhao Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Yan Zhang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Yunfeng Yao Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Tong Zhou Department of Cell Biology and Divisions of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Nan Li Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles
  • Aiwen Wu Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, ChinaDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Zhi Yang Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, ChinaNMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China PubMed articlesGoogle scholar articles

Citation

Wang S, Zhu H, Li Y, et al
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
Journal for ImmunoTherapy of Cancer 2021;9:e002926. doi: 10.1136/jitc-2021-002926
Online issue publication 
November 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.